International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset diseaseDavid Isenberg, Frederick W. Miller, Clarissa Pilkington et al.|Lara D. Veeken|2003Cited by 367
Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritisJiří Vencovský|Annals of the Rheumatic Diseases|2003Cited by 286
Novel Somatic <scp><i>UBA1</i></scp> Variant in a Patient With <scp>VEXAS</scp> SyndromeBlanka Stibůrková, Jiří Vencovský|Arthritis & Rheumatology|2023Cited by 52
Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodiesDanlei Zhou, C. Yung Yu, Emily King et al.|Annals of the Rheumatic Diseases|2022Cited by 30